Exosome engineering for efficient intracellular delivery of soluble proteins using optically reversible protein–protein interaction module DOI Creative Commons

Nambin Yim,

Seung-Wook Ryu,

Kyungsun Choi

et al.

Nature Communications, Journal Year: 2016, Volume and Issue: 7(1)

Published: July 22, 2016

Abstract Nanoparticle-mediated delivery of functional macromolecules is a promising method for treating variety human diseases. Among nanoparticles, cell-derived exosomes have recently been highlighted as new therapeutic strategy the in vivo nucleotides and chemical drugs. Here we describe tool intracellular target proteins, named ‘exosomes protein loading via optically reversible protein–protein interactions’ (EXPLORs). By integrating interaction module controlled by blue light with endogenous process exosome biogenesis, are able to successfully load cargo proteins into newly generated exosomes. Treatment protein-loaded EXPLORs shown significantly increase levels their function recipient cells vitro . These results clearly indicate potential mechanism efficient transfer protein-based therapeutics tissues.

Language: Английский

PEGylation as a strategy for improving nanoparticle-based drug and gene delivery DOI
Jung Soo Suk, Qingguo Xu, Nam‐Ho Kim

et al.

Advanced Drug Delivery Reviews, Journal Year: 2015, Volume and Issue: 99, P. 28 - 51

Published: Oct. 19, 2015

Language: Английский

Citations

3419

Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy DOI
Lena M. Kranz, Mustafa Diken, Heinrich Haas

et al.

Nature, Journal Year: 2016, Volume and Issue: 534(7607), P. 396 - 401

Published: June 1, 2016

Language: Английский

Citations

1482

Trends in peptide drug discovery DOI
Markus Muttenthaler, Glenn F. King, David J. Adams

et al.

Nature Reviews Drug Discovery, Journal Year: 2021, Volume and Issue: 20(4), P. 309 - 325

Published: Feb. 3, 2021

Language: Английский

Citations

1333

Bioresponsive materials DOI
Yue Lü, Alex A. Aimetti, Róbert Langer

et al.

Nature Reviews Materials, Journal Year: 2016, Volume and Issue: 2(1)

Published: Oct. 25, 2016

Language: Английский

Citations

1289

Biomimetic mineralization of metal-organic frameworks as protective coatings for biomacromolecules DOI Creative Commons
Kang Liang, Raffaele Riccò, Cara M. Doherty

et al.

Nature Communications, Journal Year: 2015, Volume and Issue: 6(1)

Published: June 4, 2015

Abstract Enhancing the robustness of functional biomacromolecules is a critical challenge in biotechnology, which if addressed would enhance their use pharmaceuticals, chemical processing and biostorage. Here we report novel method, inspired by natural biomineralization processes, provides unprecedented protection encapsulating them within class porous materials termed metal-organic frameworks. We show that proteins, enzymes DNA rapidly induce formation protective framework coatings under physiological conditions concentrating building blocks facilitating crystallization around biomacromolecules. The resulting biocomposite stable normally decompose many biological macromolecules. For example, urease horseradish peroxidase protected shell are found to retain bioactivity after being treated at 80 °C boiled dimethylformamide (153 °C), respectively. This rapid, low-cost biomimetic mineralization process gives rise new possibilities for exploitation

Language: Английский

Citations

1268

Therapeutic peptides: current applications and future directions DOI Creative Commons
Lei Wang, Nanxi Wang,

Wenping Zhang

et al.

Signal Transduction and Targeted Therapy, Journal Year: 2022, Volume and Issue: 7(1)

Published: Feb. 14, 2022

Abstract Peptide drug development has made great progress in the last decade thanks to new production, modification, and analytic technologies. Peptides have been produced modified using both chemical biological methods, together with novel design delivery strategies, which helped overcome inherent drawbacks of peptides allowed continued advancement this field. A wide variety natural obtained studied, covering multiple therapeutic areas. This review summarizes efforts achievements peptide discovery, their current applications. We also discuss value challenges associated future developments peptides.

Language: Английский

Citations

1182

Diverse Applications of Nanomedicine DOI Creative Commons
Beatriz Pelaz, Christoph Alexiou, Ramón A. Álvarez‐Puebla

et al.

ACS Nano, Journal Year: 2017, Volume and Issue: 11(3), P. 2313 - 2381

Published: March 14, 2017

The design and use of materials in the nanoscale size range for addressing medical health-related issues continues to receive increasing interest. Research nanomedicine spans a multitude areas, including drug delivery, vaccine development, antibacterial, diagnosis imaging tools, wearable devices, implants, high-throughput screening platforms, etc. using biological, nonbiological, biomimetic, or hybrid materials. Many these developments are starting be translated into viable clinical products. Here, we provide an overview recent highlight current challenges upcoming opportunities field translation clinic.

Language: Английский

Citations

1178

Nanoparticles in the clinic DOI Creative Commons
Aaron C. Anselmo, Samir Mitragotri

Bioengineering & Translational Medicine, Journal Year: 2016, Volume and Issue: 1(1), P. 10 - 29

Published: March 1, 2016

Nanoparticle/microparticle-based drug delivery systems for systemic (i.e., intravenous) applications have significant advantages over their nonformulated and free counterparts. For example, nanoparticle are capable of delivering therapeutics treating areas the body that other cannot reach. As such, imaging one most investigated in preclinical clinical settings. Here, we will highlight diversity types, key these counterparts, discuss overall potential influencing care. In particular, focus on current trials formulations yet to be clinically approved. Additional emphasis approved systems, both currently indications use active trials. Finally, many often overlooked biological, technological, study design challenges impact success systems.

Language: Английский

Citations

1151

Controlled Drug Delivery Systems: Current Status and Future Directions DOI Creative Commons
Shivakalyani Adepu, Seeram Ramakrishna

Molecules, Journal Year: 2021, Volume and Issue: 26(19), P. 5905 - 5905

Published: Sept. 29, 2021

The drug delivery system enables the release of active pharmaceutical ingredient to achieve a desired therapeutic response. Conventional systems (tablets, capsules, syrups, ointments, etc.) suffer from poor bioavailability and fluctuations in plasma level are unable sustained release. Without an efficient mechanism, whole process can be rendered useless. Moreover, has delivered at specified controlled rate target site as precisely possible maximum efficacy safety. Controlled developed combat problems associated with conventional delivery. There been tremendous evolution past two decades ranging macro scale nano intelligent targeted initial part this review provides basic understanding emphasis on pharmacokinetics drug. It also discusses their limitations. Further, discussed detail design considerations, classifications drawings. In addition, nano-drug delivery, smart using stimuli-responsive biomaterials is recent key findings. paper concludes challenges faced future directions

Language: Английский

Citations

974

The Current State of Peptide Drug Discovery: Back to the Future? DOI

Antoine Henninot,

James C. Collins,

John M. Nuss

et al.

Journal of Medicinal Chemistry, Journal Year: 2017, Volume and Issue: 61(4), P. 1382 - 1414

Published: July 24, 2017

Over the past decade, peptide drug discovery has experienced a revival of interest and scientific momentum, as pharmaceutical industry come to appreciate role that therapeutics can play in addressing unmet medical needs how this class compounds be an excellent complement or even preferable alternative small molecule biological therapeutics. In Perspective, we give concise description recent progress holistic manner, highlighting enabling technological advances affecting nearly every aspect field: from lead discovery, synthesis optimization, delivery. An emphasis is placed on describing research efforts overcome inherent weaknesses drugs, particular their poor pharmacokinetic properties, these have been critical design, subsequent development novel

Language: Английский

Citations

945